A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection.
Hepatocellular carcinoma (HCC) is the most frequent malignant tumour of the liver. The risk of HCC in chronically hepatitis B virus (HBV) infected individuals is approximately 100-fold higher than in the uninfected population. Despite all therapeutic advances, the benefit of systemic chemotherapy in patients with HCC has limited. But, the phase III clinical trial conducted in patients with advanced HCC treated with sorafenib has showed significant improvements in both overall and progression-free survival Metastasis from liver to extrahepatic tissues is reported to be quite uncommon and has a poor prognosis. Here we present a case of HCC which metastasized to the vertebrae, lung and kidney in order of appearance and controlled with immunotherapy and antiviral therapy following resection.
Kilickap
Saadettin
S
Department of Medical Oncology, Hacettepe University Institute of Oncology, Sihhiye, Ankara 06100, Turkey. skilickap@yahoo.com
Kars
Ayse
A
Hamaloglu
Erhan
E
Simsek
Halis
H
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000556:secondary / Q000628:therapy* / Q000821:virology; D003131:Combined Modality Therapy; D004279:DNA, Viral / Q000235:genetics; D006498:Hepatectomy; D006509:Hepatitis B / Q000473:pathology / Q000628:therapy* / Q000821:virology; D006515:Hepatitis B virus / Q000302:isolation & purification; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000556:secondary / Q000628:therapy / Q000821:virology; D008113:Liver Neoplasms / Q000473:pathology / Q000628:therapy* / Q000821:virology; D008175:Lung Neoplasms / Q000556:secondary / Q000628:therapy / Q000821:virology; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy* / Q000821:virology
D000998:Antiviral Agents; D004279:DNA, Viral; D016898:Interferon-alpha
Lancet. 1981 Nov 21;2(8256):1129-33
6118576
Ann Oncol. 2000 Sep;11(9):1195-6
11061618
Ann Surg Oncol. 2003 Nov;10(9):1070-6
14597446
Br J Surg. 1998 Sep;85(9):1198-200
9752858
J Formos Med Assoc. 1994 Jan;93(1):71-4
7915586
N Engl J Med. 2004 Oct 7;351(15):1521-31
15470215
Br J Surg. 1994 Jul;81(7):1019-21
7922051
Br J Cancer. 2001 May;84 Suppl 2:74-7
11355975
Eur J Gastroenterol Hepatol. 2005 May;17(5):497-503
15827439
Int J Cancer. 2001 Oct 15;94(2):153-6
11668491
J Gastroenterol Hepatol. 2005 Nov;20(11):1781-7
16246200
Eur J Gastroenterol Hepatol. 2001 Sep;13(9):1083-8
11564960
Radiology. 2000 Sep;216(3):698-703
10966697
Semin Liver Dis. 2004 Feb;24(1):77-88
15085488
Dig Surg. 2001;18(4):294-7
11528139
J Clin Oncol. 2001 Jun 15;19(12):3037-44
11408499
World J Gastroenterol. 2001 Aug;7(4):445-54
11819809
World J Gastroenterol. 2000 Jun;6(3):339-343
11819593
Semin Liver Dis. 1999;19(3):253-62
10518305
Am Surg. 2003 Oct;69(10):879-85
14570367
Hepatology. 2003 Jun;37(6):1309-19
12774009
Cancer. 2001 Apr 15;91(8):1479-86
11301395
J Gastroenterol Hepatol. 1997 Oct;12(9-10):S294-308
9407350
Urol Int. 2004;73(1):89-91
15263801
J Hepatol. 2005 Feb;42(2):188-94
15664243
Ann Nucl Med. 2003 Jun;17(4):333-6
12932119
Gastroenterology. 2004 Jan;126(1):102-10
14699492
Cancer. 2000 Aug 1;89(3):500-7
10931448